TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 92 filers reported holding TRICIDA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,015,000 | +1228.2% | 287,603 | +1127.6% | 0.01% | – |
| Q2 2022 | $227,000 | -68.5% | 23,429 | -73.4% | 0.00% | -100.0% |
| Q1 2022 | $721,000 | +32.1% | 87,914 | -14.9% | 0.00% | -66.7% |
| Q1 2021 | $546,000 | -50.5% | 103,282 | -15.1% | 0.00% | -57.1% |
| Q3 2020 | $1,102,000 | -78.4% | 121,660 | -7.7% | 0.01% | -70.8% |
| Q1 2019 | $5,092,000 | – | 131,824 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 7,132,079 | $69,039,000 | 13.60% |
| STONEHILL CAPITAL MANAGEMENT LLC | 1,436,736 | $13,908,000 | 9.25% |
| COMMODORE CAPITAL LP | 2,028,453 | $19,635,000 | 4.15% |
| Tri Locum Partners LP | 731,142 | $7,077,000 | 2.90% |
| GREAT POINT PARTNERS LLC | 1,164,763 | $11,275,000 | 2.70% |
| Frazier Life Sciences Management, L.P. | 2,082,093 | $20,155,000 | 1.90% |
| Orbimed Advisors | 10,280,947 | $99,520,000 | 1.80% |
| Deep Track Capital, LP | 2,732,117 | $26,447,000 | 1.74% |
| Lion Point Capital, LP | 1,826,729 | $12,034,000 | 1.37% |
| Bleichroeder LP | 450,000 | $4,356,000 | 0.90% |